Advertisements



Divis Labs tanks 20% after USFDA issues import alert on Vizag unit

The stock tanked 20% to Rs 635, also its 52-week low on BSE in intra-day on back of heavy volumes......»»

Category: topSource: business-standardMar 21st, 2017

Resolved all issues leading to USFDA import alert on Vizag unit: Divis Labs

BS ReporterHyderabad, 20 September: Hyderabad-based Divis Laboratories Limited on Wednesday said Unit 2 in Visakhapatnam, which has been under import alert for the past six months, has resolved all the previous observations of.....»»

Category: topSource: business-standardSep 20th, 2017

Divi"s Labs gains as USFDA closes out warning letter for Vizag unit

Thus far in the current month, Divi's Labs outperformed the market by gaining 23% after the company on November 2, said that the USFDA will lift import alert for its Visakhapatnam unit......»»

Category: topSource: business-standardNov 9th, 2017

USFDA adds one more clause to import alert on Divi"s Labs

BS ReporterHyderabad, 22 March: The US Food and Drug Administration(US FDA) has invoked one more clause with regard to the import alert issued to Unit-2 of Hyderabad-based Divis Laboratories Limited, this time charging the company w.....»»

Category: topSource: business-standardMar 22nd, 2017

Divi"s Labs barred from exports to US after FDA import alert on Vizag unit

Hyderabad, 21 March:In a big setback to Hyderabad-based active pharmaceutical ingredients(APIs) maker Divis Laboratories Limited, the US Food and Drug Administration(US FDA) has issued import alert on the company's Unit 2 facility.....»»

Category: topSource: business-standardMar 21st, 2017

USFDA lifts import alert on Divi"s Labs" Vishakhapatnam unit

The USFDA in March had issued import alert under clauses 99-32 and 66-40 and a warning letter later for the Visakhapatnam facility for non-compliance of good manufacturing practices.....»»

Category: topSource: business-standardNov 15th, 2017

USFDA lifts import alert on Divi"s Vizag plant

BS ReporterHyderabad, 2 November: US Food and Drug Administration(USFDA) informed Hyderabad-based Divis Laboratories Limited that it will be lifting the import alert 66-40 and also moving to close out the Warning Letter issued to th.....»»

Category: topSource: business-standardNov 2nd, 2017

Divi"s Labs surges 21% as USFDA to lift import alert for Visakhapatnam unit

The stock surged 21% to Rs 1,117 on the BSE in early morning trade on back of nearly four-fold jump in trading volumes......»»

Category: topSource: business-standardNov 2nd, 2017

Divis Labs surges as USFDA to lift import alert at Visakhapatnam facility

The stock surges 20% to Rs 816 on BSE in intra-day trade.....»»

Category: topSource: business-standardJul 10th, 2017

USFDA issues warning letter to Divis Labs for Vishakhapatnam unit

Company, however, did not provide details of the warning letter.....»»

Category: topSource: business-standardApr 22nd, 2017

One-third of Divi"s scrip value melts down in two sessions

Possible import alert after USFDA remarks about firm's Vizag unit drags stock down to two-year low.....»»

Category: topSource: business-standardDec 26th, 2016

A third of Divi"s scrip value evaporates in two trading sessions

Possible import alert after USFDA remarks about firm's Vizag unit drags stock down to two-year low.....»»

Category: topSource: business-standardDec 26th, 2016

US FDA lifts import alert on Divi"s Lab Vizag unit in record seven months

This is seen as unprecedented for Indian drug makers.....»»

Category: topSource: business-standardNov 2nd, 2017

USFDA issues alert on Dr Reddy"s Hyderabad unit

Recently, USFDA had issued a Form-483 with two observations after inspecting co's unit.....»»

Category: topSource: business-standardApr 29th, 2017

US FDA issues warning letter for Divi"s Laboratories" Visakhapatnam unit

Last month, US drug regulator had issued an import alert on the products manufactured from this unit.....»»

Category: topSource: business-standardApr 24th, 2017

Divi"s Labs" Vizag unit gets warning letter from USFDA

BS Reporter Hyderabad, 22 AprilDivi'sLaboratories has informed the stock exchanges that the US drug regulator hasissued a warning letter for its unit-II at Visakhapatnam, Andhra Pradesh. "We willrespond to this warning letter with .....»»

Category: topSource: business-standardApr 22nd, 2017

USFDA warning to Wockhardt"s Ankleshwar plant over data integrity issues

Three of firm's units under import alert; FDA cites failure to check microbiological contamination.....»»

Category: topSource: business-standardJan 3rd, 2017

Divi"s Laboratories Vizag unit receives USFDA EIR with six observations

The USFDA releases a copy of the EIR to the establishment that was the subject of an FDA inspection.....»»

Category: topSource: business-standardNov 18th, 2017

Lupin tanks 17%, hits over 3-year low as USFDA issues warning letter

The stock tanked 15% to Rs 880 on the BSE, trading at its lowest level since January 1, 2014......»»

Category: topSource: business-standardNov 7th, 2017

Hopes keep Divi"s Labs stock elevated

Street hopes for quick resolution, even as import alert impacts biz.....»»

Category: topSource: business-standardNov 1st, 2017

Dr Reddy"s Labs gains as Srikakulam SEZ Unit II get EIR from USFDA

The stock moved higher by nearly 7% to Rs 2,466 on BSE in an otherwise weak market.....»»

Category: topSource: business-standardSep 21st, 2017